These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Impressive lipid changes following hypolipidaemic drug administration can unveil subclinical hyperthyroidism.
    Author: Liberopoulos E, Miltiadous G, Elisaf M.
    Journal: Diabetes Obes Metab; 2001 Apr; 3(2):97-8. PubMed ID: 11298731.
    Abstract:
    It is well known that thyroid hormones modulate lipoprotein metabolism. Thus, the presence of clinical or subclinical hyperthyroidism may influence lipid parameters of dyslipidaemic patients and the efficacy of hypolipidaemic therapy. Here we present a patient with mixed hyperlipidaemia whose impressive improvement of his lipid profile following ciprofibrate administration pointed towards the diagnosis of asymptomatic underlying subclinical hyperthyroidism.
    [Abstract] [Full Text] [Related] [New Search]